Vendor Drug Program Updates
DUR Board Meeting Scheduled for Oct. 22 and 23
The next Texas Drug Utilization Review Board will take place over two days. Thursday, Oct. 22 is scheduled to allow public testimony regarding the new drug classes: anticonvulsants, antihemophilic, antineoplastic (i.e., anti-cancer), antiretroviral (i.e., anti-HIV), and medications used to treat multiple sclerosis. The remainder of the meeting takes place Friday, Oct. 23. Registration is forthcoming.
Pharmacy Provider Email Addresses Requested
HHSC and the Texas Medicaid and Healthcare Partnership (TMHP) are redesigning the current provider enrollment revalidation process for all providers with a new online portal. The new Provider Enrollment and Management System will begin in early 2021. Pharmacy providers enrolled with VDP can start requesting a TMHP portal account beginning mid-Dec. 2020. To accommodate this change, VDP requests enrolled pharmacy providers ensure their contact information is update.
Reminders
|
